Evidence map›Paper›PMID 36432127›Full record

ArticleMolecules (Basel, Switzerland)2022

The New Strategy for Studying Drug-Delivery Systems with Prolonged Release: Seven-Day In Vitro Antibacterial Action.

Anna A Skuredina, Tatiana Yu Kopnova, Anastasia S Tychinina, Sergey A Golyshev, Irina M Le-Deygen, Natalya G Belogurova, Elena V Kudryashova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna A SkuredinaDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0003-0201-5495
Tatiana Yu KopnovaDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0001-5196-5863
Anastasia S TychininaDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.
Sergey A GolyshevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
Irina M Le-DeygenDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-6366-4491
Natalya G BelogurovaDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.
Elena V KudryashovaDepartment of Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia.ORCID 0000-0002-9761-7757

Funding

Russian Science Foundation 22-24-00604
6 · The paper itself

Abstract

The new method of antibacterial-drug-activity investigation in vitro is proposed as a powerful strategy for understanding how carriers affect drug action during long periods (7 days). In this paper, we observed fluoroquinolone moxifloxacin (MF) antibacterial-efficiency in non-covalent complexes, with the sulfobutyl ether derivative of β-cyclodextrin (SCD) and its polymer (SCDpol). We conducted in vitro studies on two

Indexed as

Anti-Bacterial AgentsEscherichia coli InfectionsBacteriaDrug CarriersEscherichia coliHumansPolymersAnti-Bacterial AgentsDrug CarriersPolymersadsorptionantibacterial activitycyclodextrinfluoroquinolonesin vitroparticle adsorption visualizationTEM

Identifiers

PMID36432127
PMCPMC9695913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.